Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L M Fuller

Showing results (81-90 of 116) with videos related to

Pageof 12
Sort By:
Cancer Treatment Reports|September 1, 1977
Team approach to management of non-Hodgkin's lymphomas: past and presentL M Fuller, J F Gamble, J J Butler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphomaS Jagannath, W S Velasquez, S L Tucker, et al.
Cancer Treatment Reports|April 1, 1982
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPPF B Hagemeister, L M Fuller, W S Velasquez, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
Long-term results with radiotherapy for Stage I-II follicular lymphomasR B Wilder, D Jones, S L Tucker, et al.
Cancer|June 1, 1980
Laparotomy findings in lymphangiogram-staged I and non-Hodgkin's lymphomasL J Heifetz, L M Fuller, R W Rodgers, et al.
Cancer|November 1, 1976
Radiation-related myocardial injury. Management of two casesM K Ali, K G Kahlil, L M Fuller, et al.
Radiology|December 1, 1981
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomyF B Hagemeister, L M Fuller, J A Sullivan, et al.
Leukemia & Lymphoma|April 1, 1993
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicityJ C Liang, N M Bailey, G J Gabriel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's diseaseF B Hagemeister, L M Fuller, W S Velasquez, et al.
Cancer|May 1, 1994
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysisW S Velasquez, P McLaughlin, L M Fuller, et al.
Pageof 12

Showing results (81-90 of 116) with videos related to

Sort By:
Pageof 12
Cancer Treatment Reports|September 1, 1977
Team approach to management of non-Hodgkin's lymphomas: past and presentL M Fuller, J F Gamble, J J Butler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1986
Tumor burden assessment and its implication for a prognostic model in advanced diffuse large-cell lymphomaS Jagannath, W S Velasquez, S L Tucker, et al.
Cancer Treatment Reports|April 1, 1982
Stage I and II Hodgkin's disease: involved-field radiotherapy versus extended-field radiotherapy versus involved-field radiotherapy followed by six cycles of MOPPF B Hagemeister, L M Fuller, W S Velasquez, et al.
International Journal of Radiation Oncology, Biology, Physics|December 1, 2001
Long-term results with radiotherapy for Stage I-II follicular lymphomasR B Wilder, D Jones, S L Tucker, et al.
Cancer|June 1, 1980
Laparotomy findings in lymphangiogram-staged I and non-Hodgkin's lymphomasL J Heifetz, L M Fuller, R W Rodgers, et al.
Cancer|November 1, 1976
Radiation-related myocardial injury. Management of two casesM K Ali, K G Kahlil, L M Fuller, et al.
Radiology|December 1, 1981
Treatment of stage I and II mediastinal Hodgkin disease. A comparison of involved fields, extended fields, and involved fields followed by MOPP in patients staged by laparotomyF B Hagemeister, L M Fuller, J A Sullivan, et al.
Leukemia & Lymphoma|April 1, 1993
A new chemotherapy regimen for treatment of Hodgkin's disease associated with minimal genotoxicityJ C Liang, N M Bailey, G J Gabriel, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Two cycles of MOPP and radiotherapy: effective treatment for stage IIIA and IIIB Hodgkin's diseaseF B Hagemeister, L M Fuller, W S Velasquez, et al.
Cancer|May 1, 1994
Intermediate-grade lymphomas treated with cyclophosphamide-doxorubicin- vincristine-prednisone-bleomycin alternated with cyclophosphamide-methotrexate-etoposide-dexamethasone. Application of prognostic models to data analysisW S Velasquez, P McLaughlin, L M Fuller, et al.
Pageof 12